The mixed Q1 financial results indicate that while some financial metrics may not have met expectations, others did, or there were positive aspects that investors found appealing. The announcement of an exclusive distribution agreement in Qatar is likely viewed as a significant positive development, indicating potential for revenue growth and market expansion. These factors combined are likely contributing to the positive movement in T2 Biosystems' stock price.